Stocks
Allogene Therapeutics (ALLO) ROA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROA, % | ? | -25.7% | -19.0% | -23.6% | -40.4% | -50.9% | -48.1% | ||
| Changes by years, y/y, % | +2pp | +7pp | -5pp | -17pp | -11pp | +13.2% | |||
Allogene Therapeutics. ROA, %
Allogene Therapeutics. ROA, changes, pp
Allogene Therapeutics (ALLO) ROA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROA, % | ? | -46.5% | -50.3% | -49.5% | -43.0% | -48.1% | -48.1% | |
| Changes by years, y/y, % | -11pp | -10pp | -3pp | +3pp | -2pp | |||
| Changes by quarters, q/q, % | -1pp | -4pp | +1pp | +6pp | -5pp | |||
